Profile data is unavailable for this security.
About the company
Aoti, Inc. is engaged in wound care technology around the world. The Company is focused on helping all people with chronic conditions get back to living their lives to the fullest. It does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.
- Revenue in GBP (TTM)46.82m
- Net income in GBP1.73m
- Incorporated2008
- Employees80.00
- LocationAoti Inc3512 Seagate Way, Suite 100OCEANSIDE 92056United StatesUSA
- Phone+1 (760) 431-4700
- Fax+1 (760) 683-3063
- Websitehttps://aotinc.net/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verici DX PLC | 1.40m | -5.58m | 10.44m | 15.00 | -- | 0.9197 | -- | 7.45 | -0.023 | -0.023 | 0.0058 | 0.0075 | 0.2298 | -- | 1.67 | 77,916.49 | -91.48 | -- | -119.40 | -- | 81.60 | -- | -398.12 | -- | -- | -- | 0.102 | -- | 229.62 | -- | 32.75 | -- | -- | -- |
| Genedrive PLC | 954.00k | -5.23m | 11.33m | 43.00 | -- | 4.78 | -- | 11.87 | -0.0093 | -0.0093 | 0.0017 | 0.0023 | 0.1984 | -- | 1.80 | 22,186.05 | -108.81 | -77.52 | -153.92 | -106.30 | -- | -- | -548.32 | -1,016.12 | 1.64 | -- | 0.00 | -- | 90.42 | -2.07 | 26.06 | -- | -10.48 | -- |
| Cellbxhealth PLC | 2.62m | -15.78m | 11.96m | 119.00 | -- | 0.2897 | -- | 4.56 | -0.0489 | -0.0489 | 0.0081 | 0.0362 | 0.1028 | 0.5939 | 1.46 | 22,050.42 | -61.80 | -41.90 | -72.78 | -46.81 | 62.27 | 18.55 | -601.37 | -1,051.13 | 2.63 | -470.57 | 0.2387 | -- | 30.92 | -- | 29.34 | -- | -- | -- |
| Abingdon Health PLC | 8.43m | -3.42m | 15.06m | 121.00 | -- | 2.19 | -- | 1.79 | -0.0176 | -0.0176 | 0.0435 | 0.0274 | 1.17 | 9.71 | 3.87 | 69,661.16 | -47.42 | -54.04 | -70.70 | -85.91 | 44.32 | 30.37 | -40.51 | -110.07 | 1.58 | -- | 0.1625 | -- | 37.39 | 9.99 | -168.69 | -- | -26.92 | -- |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m | 15.47m | 214.00 | -- | 0.9449 | -- | 0.3422 | -0.1275 | -0.1275 | 0.5038 | 0.1826 | 1.03 | 2.00 | 5.91 | 211,215.00 | -25.96 | -6.05 | -33.03 | -7.45 | 44.39 | 46.62 | -25.32 | -7.01 | 1.11 | 2.42 | 0.441 | -- | 1.65 | 16.56 | -148.04 | -- | 39.05 | -- |
| Renalytix PLC | 2.20m | -14.96m | 24.47m | 45.00 | -- | -- | -- | 11.13 | -0.0596 | -0.0596 | 0.008 | -0.0155 | 0.4547 | 7.64 | 4.54 | -- | -309.18 | -83.70 | -- | -107.25 | 40.00 | 28.27 | -680.00 | -1,519.31 | 1.17 | -24.57 | 6.38 | -- | 31.06 | -- | 55.14 | -- | -- | -- |
| Aptamer Group PLC | 1.20m | -2.42m | 25.62m | 31.00 | -- | 13.69 | -- | 21.30 | -0.0014 | -0.0014 | 0.0007 | 0.0007 | 0.4294 | 6.27 | 4.35 | 38,806.45 | -86.53 | -- | -154.00 | -- | 48.13 | -- | -201.50 | -- | 1.48 | -84.63 | 0.2622 | -- | 39.88 | -- | 18.05 | -- | -- | -- |
| Aoti Inc | 46.82m | 1.73m | 44.83m | 80.00 | 21.32 | 3.45 | 13.03 | 0.9576 | 0.0198 | 0.0198 | 0.4704 | 0.1223 | 1.32 | 2.17 | 4.65 | -- | 4.87 | -- | 6.54 | -- | 88.13 | -- | 3.69 | -- | 2.54 | 2.81 | 0.5269 | -- | 32.88 | -- | 78.55 | -- | -- | -- |
| Ondine Biomedical Inc | 1.19m | -12.93m | 48.14m | 43.00 | -- | 104.83 | -- | 40.39 | -0.0355 | -0.0355 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| Creo Medical Group PLC | 2.20m | 12.60m | 72.18m | 133.00 | 5.92 | 1.19 | 5.19 | 32.81 | 0.0296 | 0.0272 | 0.0056 | 0.1477 | 0.0319 | -0.8034 | 0.3308 | 16,541.35 | 18.25 | -29.25 | 20.62 | -35.89 | 45.45 | 47.22 | 572.73 | -176.82 | 4.75 | -69.50 | 0.0645 | -- | 0.00 | 212.28 | -17.30 | -- | -18.58 | -- |
| Inspecs Group PLC | 192.83m | -3.31m | 75.75m | 1.65k | -- | 0.8501 | 8.11 | 0.3928 | -0.0326 | -0.0806 | 1.90 | 0.8764 | 0.9138 | 2.31 | 7.71 | 116,586.50 | -1.57 | -2.16 | -2.31 | -3.13 | 51.86 | 49.60 | -1.72 | -2.79 | 0.8847 | 1.73 | 0.3969 | -- | -2.48 | 32.80 | -362.19 | -- | 4.97 | -- |
| SDI Group PLC | 69.29m | 4.59m | 85.75m | 504.00 | 19.07 | 1.67 | 9.46 | 1.24 | 0.043 | 0.043 | 0.6497 | 0.4923 | 0.7692 | -- | 5.78 | 137,484.10 | 5.12 | 7.08 | 5.81 | 8.87 | -- | 63.93 | 6.65 | 8.60 | 1.19 | 5.75 | 0.3363 | 0.00 | 0.5027 | 21.99 | -5.84 | 8.99 | 11.55 | -- |
| EKF Diagnostics Holdings PLC | 50.22m | 6.12m | 107.99m | 297.00 | 18.52 | 1.57 | 9.83 | 2.15 | 0.0135 | 0.0135 | 0.1109 | 0.1597 | 0.6209 | 3.16 | 7.34 | 165,745.90 | 7.98 | 5.79 | 8.77 | 6.76 | 49.79 | 49.42 | 12.86 | 8.62 | 3.47 | -- | 0.0152 | -- | -4.59 | 2.25 | 165.39 | 11.16 | 3.02 | -- |
Data as of Feb 11 2026. Currency figures normalised to Aoti Inc's reporting currency: UK Pound GBX
21.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wasatch Advisors LPas of 12 Dec 2025 | 13.01m | 12.23% |
| Artemis Investment Management LLPas of 19 Nov 2024 | 4.79m | 4.50% |
| River Global Investors LLPas of 30 Sep 2025 | 1.78m | 1.68% |
| Harwood Capital LLPas of 31 Mar 2025 | 1.00m | 0.94% |
| Fondita Fund Management Co. Ltd.as of 31 Dec 2025 | 858.86k | 0.81% |
| Cooke & Bieler LPas of 30 Sep 2025 | 840.32k | 0.79% |
| West Yorkshire Pension Fundas of 31 Mar 2025 | 379.02k | 0.36% |
| Warburg Invest Kapitalanlagegesellschaft MBHas of 31 May 2025 | 260.00k | 0.24% |
| Slater Investments Ltd.as of 30 Jul 2025 | 147.73k | 0.14% |
| Toscafund Asset Management LLPas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
